The team at BioPortUSA has been asked to present to a group of 17 Swiss Medical Device start-ups on what it takes to be successful in the USA including how to navigate the regulatory pathway. “I am delighted to have been invited by Swissnex to present live to this delegation of Swiss Medtech companies who will be showcasing some of the newest and innovative technology to come out of Switzerland said Mark Lesselroth, CEO of BioPortUSA.”
Swissnex is the world’s first science consulate whose vision is to help “unlock a new generation of ideas for Switzerland and the world of tomorrow.” Alicia Evangelista, Head of Innovation stated that “we’re in the business of creating aha moments, working on the frontiers of education, research and innovation.”
Given the vast network of resources BioPortUSA has at its disposal, they are in a unique position to help life science companies, including start-ups with helping get their technology commercialized in the United States.